Capitol Health on the prowl

Further share price growth depends on the diagnostic imaging company making an accretive acquisition interstate … at least for the short term.

Since initially calling Capitol Health (CAJ) as a “buy” July 2, the stock has run up from 42 cents to a high of 72 cents and closed at 64 cents today. Although the share price movement has been in our favour it is currently a tough one to call in the 60-70 cents range.

When I initially recommended CAJ the valuation was 54 cents. This valuation didn’t assume further acquisitions or an entry into the NSW and/or Queensland diagnostic imaging market.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles